Vanishing Batteries

Researchers describe a major component of biodegradable implants.

Written byRina Shaikh-Lesko
| 1 min read

Register for free to listen to this article
Listen with Speechify
0:00
1:00
Share

A biodegradable chip developed by the Rogers Lab in 2012UNIVERSITY OF ILLINOIS AT URBANA-CHAMPAIGNBiodegradable components of temporary implantable devices have been in the works for several years. Now, a team led by John Rogers of the University of Illinois at Urbana-Champaign has developed a biodegradable battery source for these devices, according to a study published last week (March 20) in Advanced Materials.

This advance follows on the heels of biodegradable silicon chips that Rogers’s team developed in 2012. The chips can monitor temperature and transmit the data via radio signals or heat up enough to prevent infections. But they rely on external power sources. “Almost all of the key building blocks are now available” to produce self-powered, biodegradable implants, Rogers told Nature News.

The biodegradable battery uses magnesium foil anodes, cathodes of iron, molybdenum, or tungsten, and a phosphate-buffered saline solution electrolyte. All these compounds are biocompatible and will slowly dissolve in the body at non-toxic levels. The team created a battery with four stacked cells. Its voltage depends on the materials used. A stacked magnesium-molybdenum battery produces enough energy to power a single LED light source.

...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member? Login Here

Related Topics

Meet the Author

Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies